484 related articles for article (PubMed ID: 32236858)
21. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
[TBL] [Abstract][Full Text] [Related]
22. Indeterminate nodules by the Bethesda system for reporting thyroid cytopathology in Israel: Frequency, and risk of malignancy after reclassification of follicular thyroid neoplasm with papillary-like features.
Rosenblum RC; Shtabsky A; Marmor S; Trejo L; Yaish I; Barnes S; Yehuda M; Stern N; Silman Z; Tordjman KM
Eur J Surg Oncol; 2019 Jul; 45(7):1182-1187. PubMed ID: 30928335
[TBL] [Abstract][Full Text] [Related]
23. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
Kim M; Kim JE; Kim HJ; Chung YR; Kwak Y; Park SY
J Pathol Transl Med; 2018 May; 52(3):171-178. PubMed ID: 29614546
[TBL] [Abstract][Full Text] [Related]
24. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
25. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Lowers the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories.
Al-Maghrabi H; Tashkandi M; Khayyat W; Alghamdi A; Alsalmi M; Alzahrani A; Al-Hakami H; Alqarni M
Saudi J Med Med Sci; 2022; 10(2):105-110. PubMed ID: 35602399
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Diagnostic Categories of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Thyroid Core Needle Biopsy and Its Impact on Risk of Malignancy.
Na HY; Woo JW; Moon JH; Choi JY; Jeong WJ; Kim YK; Choe JY; Park SY
Endocr Pathol; 2019 Dec; 30(4):329-339. PubMed ID: 31605276
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features.
Legesse T; Parker L; Heath J; Staats PN
J Am Soc Cytopathol; 2019; 8(1):11-17. PubMed ID: 30929754
[TBL] [Abstract][Full Text] [Related]
29. The importance of risk of neoplasm as an outcome in cytologic-histologic correlation studies on thyroid fine needle aspiration.
Chen YH; Partyka KL; Dougherty R; Cramer HM; Wu HH
Diagn Cytopathol; 2020 Dec; 48(12):1237-1243. PubMed ID: 32716614
[TBL] [Abstract][Full Text] [Related]
30. Incidence of noninvasive follicular thyroid neoplasm with papillary-like nuclear features and change in risk of malignancy for "The Bethesda System for Reporting Thyroid Cytology".
Sung S; Margolskee E; Chen D; Tiscornia-Wasserman P
J Am Soc Cytopathol; 2019; 8(3):133-140. PubMed ID: 31097289
[TBL] [Abstract][Full Text] [Related]
31. Impact of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features on Revised Bethesda System Malignancy Rates at a Single Institution.
Linhares SM; Whitfield BW; Lee AF; Gordillo D; Picado O; Jeraq M; Farrá JC; Lew JI
J Surg Res; 2020 Nov; 255():152-157. PubMed ID: 32563006
[TBL] [Abstract][Full Text] [Related]
32. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
[TBL] [Abstract][Full Text] [Related]
33. Effect of the Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision on Indian Thyroid Fine-Needle Aspiration Practice.
Rana C; Ramakant P; Goel D; Singh A; Singh K; Babu S; Mishra A
Am J Clin Pathol; 2021 Jul; 156(2):320-327. PubMed ID: 33608707
[TBL] [Abstract][Full Text] [Related]
34. Detailed fine needle aspiration cytopathology findings of noninvasive follicular thyroid neoplasm with papillary-like nuclear features with nuclear grading correlated to that of biopsy and Bethesda category and systematic review.
Kaçar Özkara S; Turan G
Diagn Cytopathol; 2023 Dec; 51(12):758-771. PubMed ID: 37688282
[TBL] [Abstract][Full Text] [Related]
35. Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.
Koshikawa T; Fujita N; Ueda N; Ota Y; Sasaki E; Murakami Y; Hosoda W; Yatabe Y; Hanai N; Higuchi M; Hirokawa M; Miyauchi A
Endocr J; 2019 May; 66(5):475-483. PubMed ID: 30867345
[TBL] [Abstract][Full Text] [Related]
36. Revised Bethesda System for Reporting Thyroid Cytology: Lessons learned from an appraisal of 5 years of experience in a central hospital.
El Hag IA; Johnston J; Alessa E; Al Shammari M
Cytopathology; 2021 Jul; 32(4):482-492. PubMed ID: 33772905
[TBL] [Abstract][Full Text] [Related]
37. Analysis of a pre-2017 follicular variant papillary thyroid carcinoma cohort reclassified as noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP): an 11-year retrospective single institution experience.
Beg S; Khan SI; Cui I; Scognamiglio T; Rao R
J Am Soc Cytopathol; 2023; 12(2):112-119. PubMed ID: 36372672
[TBL] [Abstract][Full Text] [Related]
38. Assessment of The Bethesda System for Reporting Thyroid Cytopathology.
Sauter JL; Lehrke H; Zhang X; Al Badri OT; Rodriguez-Gutierrez R; Delivanis DA; Singh Ospina N; Donegan D; Hamidi O; Iñiguez-Ariza N; Sharma A; Kittah NEN; Tamhane SU; Hurtado Andrade MD; Kotwal A; Jenkins SM; Spears G; Rivera M; Dean DS; Henry MR
Am J Clin Pathol; 2019 Sep; 152(4):502-511. PubMed ID: 31305880
[TBL] [Abstract][Full Text] [Related]
39. Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
Jeon MJ; Song DE; Jung CK; Kim WG; Kwon H; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
PLoS One; 2016; 11(12):e0167756. PubMed ID: 27936121
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound findings of noninvasive follicular thyroid neoplasm with papillary-like nuclear features compared with those of follicular variant of papillary carcinoma and encapsulated papillary carcinoma: a single-institution study in Japan.
Oshita M; Ito Y; Miyamoto T; Ota H; Nakamura T; Hirokawa M; Miya A; Miyauchi A
Endocr J; 2020 Nov; 67(11):1147-1155. PubMed ID: 32669481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
